Literature DB >> 16767209

Lidocaine hypersensitivity after subconjunctival injection.

Jaime Levy1, Tova Lifshitz.   

Abstract

CASE REPORT: We report a rare case of hypersensitivity in a 63-year-old man who received subconjunctival lidocaine, cefazolin, and gentamicin for corneal abscess. Significant palpebral swelling and erythema were observed several hours after the injection. Nine months later, he received subconjunctival lidocaine, vanco-mycin, and ceftazidime for a new corneal abscess. After several hours, the eyelids were red and swollen, with mild blistering and scaling of the cheek. Two patch tests for lidocaine were negative. During follow-up, lateral tarsorrhaphy was performed under local anesthesia with lidocaine; erythema and swelling of eyelids and cheek appeared, resolving after several days. COMMENTS: Sensitivity to lidocaine can appear after subconjunctival injection. Patch tests may be negative, but the allergy suspected by the recurrence of clinical signs after rechallenge with lidocaine. Ester anesthetics can be used for local anesthesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767209     DOI: 10.1139/I06-010

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  Comparison of two anesthetic methods for intravitreal ozurdex injection.

Authors:  V Levent Karabaş; Berna Özkan; Çiğdem Akdağ Koçer; Özgül Altıntaş; Dilara Pirhan; Nurşen Yüksel
Journal:  J Ophthalmol       Date:  2015-04-09       Impact factor: 1.909

2.  Immediate reaction to lidocaine with periorbital edema during upper blepharoplasty.

Authors:  Benjamin Presman; Vincenzo Vindigni; Ilaria Tocco-Tussardi
Journal:  Int J Surg Case Rep       Date:  2016-01-11

3.  Potentially blinding adverse drug reaction to peribulbar lignocaine anesthesia: A rare case report.

Authors:  Saurabh Deshmukh; Harsha Bhattacharjee; Krati Gupta
Journal:  Indian J Pharmacol       Date:  2020-06-03       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.